National Pension Service Has $62.36 Million Stake in Agilent Technologies, Inc. $A

National Pension Service raised its position in Agilent Technologies, Inc. (NYSE:A) by 7.0% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 469,501 shares of the medical research company’s stock after acquiring an additional 30,730 shares during the quarter. National Pension Service owned approximately 0.17% of Agilent Technologies worth $62,364,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Brighton Jones LLC increased its position in Agilent Technologies by 6.1% during the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after buying an additional 270 shares during the last quarter. Jones Financial Companies Lllp lifted its position in shares of Agilent Technologies by 15.9% in the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock valued at $602,000 after buying an additional 769 shares during the last quarter. Geneos Wealth Management Inc. boosted its stake in shares of Agilent Technologies by 54.8% during the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after acquiring an additional 212 shares during the period. Acadian Asset Management LLC increased its holdings in shares of Agilent Technologies by 16.5% during the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after acquiring an additional 758 shares during the last quarter. Finally, Sivia Capital Partners LLC bought a new stake in Agilent Technologies in the 2nd quarter valued at $273,000. 87.41% of the stock is currently owned by institutional investors and hedge funds.

Agilent Technologies Trading Up 2.6%

Shares of NYSE:A opened at $146.91 on Friday. The business’s 50 day simple moving average is $143.71 and its 200 day simple moving average is $128.62. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $163.75. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. The company has a market capitalization of $41.42 billion, a P/E ratio of 28.92, a P/E/G ratio of 2.18 and a beta of 1.24.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The firm had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. During the same period in the prior year, the company posted $1.37 EPS. The company’s revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, research analysts anticipate that Agilent Technologies, Inc. will post 6.2 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Mikael Dolsten sold 634 shares of the business’s stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the completion of the transaction, the director directly owned 4,924 shares in the company, valued at approximately $745,395.12. The trade was a 11.41% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.17% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on A shares. Robert W. Baird raised their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th. Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Royal Bank Of Canada increased their target price on Agilent Technologies from $155.00 to $185.00 and gave the stock an “outperform” rating in a research note on Thursday, August 27th. Wells Fargo & Company reduced their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. Finally, Bank of America upped their price objective on Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a report on Thursday, August 27th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $170.33.

About Agilent Technologies

Agilent Technologies, Inc is a global provider of analytical instruments, laboratory software, consumables and services used by organizations in the life sciences, diagnostics, pharmaceutical, chemical, environmental and food industries. Its solutions help customers analyze the composition and quality of substances, develop and manufacture products, and conduct research and testing.

The company’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic analysis equipment, automated electrophoresis systems, laboratory informatics software, columns and other consumables.